News Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien... Companies awaiting CV outcomes trial, and court decision in patent case
News Sanofi, Regeneron aim to undercut rivals with new RA drug New drug will be sold at around 30% discount to rivals.
News Regeneron and Inovio to aim immunotherapy at hard-to-treat b... Regeneron is to collaborate with Inovio to investigate a three-way immunotherapy combination against glioblastoma multiforme (GBM), an aggressive and hard-to-treat brain tumour.
News Regeneron and GSK to sequence UK genetic data Companies to sequence data from 500,000 volunteers from UK's Biobank.
GlaxoSmithKline GSK's new CEO Walmsley paid 25% less than predecessor Witty GlaxoSmithKline (GSK) has confirmed rumours that its incoming CEO Emma Walmsley will be paid less than her predecessor, Sir Andrew Witty.
News Sanofi/Regeneron eczema data paves way for year's biggest la... Companies look to take on Pfizer after series of setbacks.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
